EUVIMEDEUVIMED entdecken
Crossref

Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer’s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer’s Disease Continuum

Chiara Giuseppina Bonomi, Martina Assogna, Martina Gaia Di Donna, Francesca Bernocchi, Vincenzo De Lucia, Marzia Nuccetelli, Denise Fiorelli, Stefano Loizzo, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana, Caterina Motta

Journal of Alzheimer's Disease · 18.04.2023 · 92 (4) · 1385-1397

DOI: 10.3233/jad-221010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 18.04.2023. Verfasst von Chiara Giuseppina Bonomi und 11 weiteren Autor:innen. Beteiligte Einrichtung: UOSD Centro Demenze, Policlinico Tor Vergata, University of Rome 'Tor Vergata', Rome, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many transversal mechanisms act synergistically at different time-points in the cascade of Alzheimer’s disease (AD), since amyloid-β (Aβ) deposition, tau pathology, and neuroinflammation influence each other.

Objective

We explored the contributions of microglia and astrocytes in patients with symptomatic sporadic AD stratified according to AT(N) system and APOE genotype.

Methods

We compared the cerebrospinal fluid (CSF) levels of sTREM-2 and markers of astrocytic activation (GFAP; β-S100) from 71 patients with AD (23 A+T–,48 A+T+; 38 APOE ɛ3, 33 APOE ɛ4) and 30 healthy controls (HC). With multivariate analyses we investigated associations between glial biomarkers, Aβ42, and p-tau in all subgroups.

Results

CSF sTREM-2 was higher in A+T+ [1.437 (0.264)] and A+T– [1.355 (0.213)] than in HC [1.042 (0.198); both p < 0.001]; GFAP and β-S100 were comparable across groups. Considering all patients, sTREM-2 positively associated with Aβ42 (p = 0.04) and p-tau (=0.016), with the first being present only in the A+T– subgroup (p = 0.023). GFAP positively associated with Aβ42 in all patients (p = 0.020) and in the A+T+ subgroup (p = 0.04). Stratifying by APOE, a positive association of sTREM-2 and p-tau was confirmed selectively in carriers of ɛ4 (p = 0.018). Finally, sTREM-2 positively correlated with β-S100 in all subgroups, and with GFAP in A+T+ (p = 0.042).

Conclusion

Our results confirm the increase of CSF sTREM-2 in AD, which associates with reduced amyloidopathy in A+T– patients. Moreover, microglial activation seems to increase CSF tau levels in carriers of APOE ɛ4, is associated with astrocytic reactivity (GFAP) in A+T+, and likely leads the acquisition of a more neurotoxic astrocytic phenotype (β-S100).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmyloid beta-PeptidesApolipoproteins EAstrocytesBiomarkersMicrogliaPeptide Fragmentstau ProteinsS100 Calcium Binding Protein beta SubunitMembrane GlycoproteinsReceptors, ImmunologicGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

Alzheimer’s diseaseAlzheimer’s disease continuumGFAPastrocytesbiomarkersmicrogliasoluble TREM-2β-S100

Substanzen

Amyloid beta-PeptidesApolipoproteins EBiomarkersPeptide Fragmentstau ProteinsS100B protein, humanS100 Calcium Binding Protein beta SubunitTREM2 protein, humanMembrane GlycoproteinsReceptors, Immunologic

Autor:innen und Institutionen

  • UOSD Centro Demenze, Policlinico Tor Vergata, University of Rome 'Tor Vergata', Rome, Italy.
  • Non Invasive Brain Stimulation Unit, IRCCS Santa Lucia, Rome, Italy.
  • Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
  • Department of Cardiovascular, Endocrine-Metabolic and Ageing-Associated Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Neurology Unit, Policlinico Tor Vergata, University of Rome 'Tor Vergata', Rome, Italy.
  • Human Physiology Unit, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Zitieren

APA

Bonomi, C. G., Assogna, M., Di Donna, M. G., Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. B., Koch, G., Martorana, A., & Motta, C. (2023). Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer’s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer’s Disease Continuum. Journal of Alzheimer's Disease, 92(4), 1385-1397. https://doi.org/10.3233/jad-221010

Vancouver

Bonomi CG, Assogna M, Di Donna MG, Bernocchi F, De Lucia V, Nuccetelli M, et al. Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer’s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer’s Disease Continuum. Journal of Alzheimer's Disease. 2023;92(4):1385-1397. doi:10.3233/jad-221010

BibTeX
@article{Bonomi2023,
  author = {Bonomi, Chiara Giuseppina and Assogna, Martina and Di Donna, Martina Gaia and Bernocchi, Francesca and De Lucia, Vincenzo and Nuccetelli, Marzia and Fiorelli, Denise and Loizzo, Stefano and Mercuri, Nicola Biagio and Koch, Giacomo and Martorana, Alessandro and Motta, Caterina},
  title = {Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer’s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer’s Disease Continuum},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {92},
  number = {4},
  pages = {1385--1397},
  doi = {10.3233/jad-221010}
}
Kostenlos starten →